<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00696358</url>
  </required_header>
  <id_info>
    <org_study_id>NICE-VIT1</org_study_id>
    <nct_id>NCT00696358</nct_id>
  </id_info>
  <brief_title>Excimer Lamp Versus Excimer Laser in Vitiligo Treatment</brief_title>
  <official_title>Comparative Study of 308nm Excimer Lamp and 308nm Excimer Laser in the Treatment of Vitiligo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <brief_summary>
    <textblock>
      308 nm excimer lamp and 308 nm excimer laser have both provide interesting results in
      treating vitiligo. They have the same wavelength but the type of emission of the photons is
      different. To date there is no direct comparative data concerning these two devices in this
      indication.

      The aim of the study is to make an intra-individual prospective comparison between these two
      phototherapies.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Repigmentation rate in the treated areas</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerance and safety of the treatments</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Vitiligo</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>308 nm excimer lamp</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>308 nm excimer laser</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>308nm excimer lamp</intervention_name>
    <description>50 mJ/cm² below the MED (minimal erythemal dose) and progressive increase Twice a week for 12 weeks</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>308nm excimer laser</intervention_name>
    <description>50 mJ/cm² below the MED (minimal erythemal dose) and progressive increase Twice a week for 12 weeks (same doses will be used between the 2 arms)</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient above 18

          -  vitiligo for more than 3 months

          -  at least 2 vitiligo symmetric patches more than 10cm²

          -  to read and understand the inform consent

          -  to have a social security number

          -  non pregnant for women

        Exclusion Criteria:

          -  pregnant women

          -  keloids

          -  history of radiotherapy or skin cancer in the treated areas

          -  treatment for vitiligo in the past 4 weeks

          -  phototherapy in the past 12 weeks; history of photodermatosis

          -  treatment inducing photosensibilization

          -  immunosuppression

          -  patient who participated in a study in the past 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Dermatology, University Hospital of Nice</name>
      <address>
        <city>Nice</city>
        <zip>06200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2008</study_first_submitted>
  <study_first_submitted_qc>June 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2008</study_first_posted>
  <last_update_submitted>October 30, 2008</last_update_submitted>
  <last_update_submitted_qc>October 30, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2008</last_update_posted>
  <keyword>Vitiligo</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitiligo</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

